Business Wire

LR Opens an IT Hub in Athens

Share

LR Health & Beauty, the digital social selling company for high-quality health and beauty products with its head office in Ahlen/Westphalia, is expanding its IT landscape with a new near-shore IT hub in Athens. In line with its business strategy, in the future LR aims to develop and operate most of its own business applications internally. “Our business model places such specific demands on a software solution that there is no alternative to an in-house development”, emphasises Axel Koß, Vice President for Information Technology at LR. The company will therefore develop customised solutions for the sales partner segment itself, thereby strengthening its ability to create high-quality in-house IT services. The employees of the information technology and sales division based in Ahlen will work hand in hand with their new colleagues in Greece.

Key factors in the decision to choose Athens as the new location include the dynamic IT infrastructure and the rich talent pool. This strategic expansion will enable the company to further advance the digitalisation of its business processes and adapt them even further to the needs of the LR sales partners.

“The kick-off will take place in autumn 2024 with the start of the recruitment for the first IT colleagues in the areas of software development, UX, and solution design for the LR site in Athens”, says Koß. A transition phase is planned as part of the set-up. The LR business applications currently administered and developed by external service providers will be successively handed over to the in-house employees of the hub. The opening of the new centre of excellence is planned for the beginning of 2025. The IT hub will then be expanded further by the end of 2026 in close cooperation with the Greek organisation. By this time, a double-digit number of new employees will be working in the IT hub in Athens.

“We are convinced that this strategic expansion to Athens, one of the most promising IT markets in Europe, will further advance our vision of a future-oriented IT landscape”, says Dr Andreas Laabs, CEO of the LR Group. “The 'IT hub' project offers us decisive advantages. On the one hand, LR is bringing IT expertise in-house that was previously supplied by external service providers and, on the other hand, we are reducing our dependence on these strategically important resources for our company”.

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe.

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240813065087/en/

Contacts

LR Health & Beauty Systems GmbH
Almut Kellermeyer
Head of Corporate Communication
Kruppstraße 55
59227 Ahlen, Germany
Tel.: +49(0)2382 7813-106
Email: a.kellermeyer@LRworld.com
https://lrworld.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Flrworld.com&es
heet=54108529&newsitemid=20240813065087&lan=en-US&anchor=https%3A%2F%2Flrworld.c
om&index=2&md5=f1855eea40b7a0aa7589e3f9a877e366

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer14.9.2024 18:45:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results, presented during a mini-oral presentation at the European Society of Medical Oncology (ESMO) with new, updated data shared during the Company’s investor event, highlight the potential of INCB123667 as a differentiated treatment option for cancers with increased Cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 dependency. In the trial, patients with advanced or metastatic solid tumors (n=205) – including ovarian cancer, endometrial cancer, gastrointestinal cancer, HR+/HER2- breast cancer and triple negative breast cancer, among others – received varying doses of INCB123667 ranging from 50mg to 150mg using once-daily (QD) and twice-daily (BID) dosing schedules. New data from the Phase 1b dose expansion portion of the trial (data cut-off August 26, 2024) presen

Incyte’s Retifanlimab (Zynyz ® ) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium14.9.2024 16:30:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced results from the Phase 3 POD1UM-303/InterAACT2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy (carboplatin–paclitaxel) for the treatment of adults with inoperable locally recurrent or metastatic squamous cell anal carcinoma (SCAC). These data were featured today in a Presidential Symposium (LBA 2) at the European Society for Medical Oncology (ESMO) Congress 2024, held in Barcelona and virtually. The POD1UM-303/InterAACT2 trial results build on previously announced topline results, showing that the study met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with SCAC not previously treated with systemic therapy, as assessed by blinded independent central review (BICR) using RECIST v1.1. Adding retifanlimab to standard of care chemotherapy res

Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience14.9.2024 10:00:00 CEST | Press release

Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This collaboration integrates Bitmovin’s renowned Player and Analytics suite into Irdeto Experience, the award-winning streaming platform trusted by top-tier operators worldwide. Together, they will provide streaming service providers, content owners, and pay-TV operators with cutting-edge solutions that address the critical need for low-latency streaming. The combination of Irdeto’s expertise in security and Bitmovin’s preeminent player offers a powerful and comprehensive solution. This joint offering allows operators to benefit from smooth, high-resolution streaming and advanced advertising and security features. The collaboration also enables operators to extend device reach by covering a wider range of devices in the Smart TV market. Whether for liv

SCF Acquires Newpark Fluids Systems14.9.2024 02:40:00 CEST | Press release

SCF Partners, Inc. (“SCF”) is pleased to announce its acquisition of the Newpark Fluids Systems business (“NFS”), a leading global pure-play oil & gas and geothermal fluids solution provider, from Newpark Resources Inc. (NYSE: NR). Newpark Fluids Systems provides a full range of drilling & completion products and related technical services supported by an innovative digital modeling software suite, global supply chain and infrastructure to enhance the efficiency and productivity of our customers’ performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240913427560/en/ Newpark Fluid Systems’ CEO, David Paterson, commented, “We are thrilled to partner with SCF. This new partnership will be a source of enormous value creation for both our customers and the entire Newpark Fluids Systems team. Our global strategic growth plan will now accelerate under a new and focused board with significant energy experience and commitment.

Important Looking Pirates Wins Its Third Creative Arts Emmy Award for Its Work on the FX Series Shōgun13.9.2024 18:00:00 CEST | Press release

Philip Engström, VFX Supervisor and Chelsea Mirus, VFX Production Manager represented Important Looking Pirates (“ILP”) on the Shōgun ballot at the award ceremony in Los Angeles, winning the Emmy in the Special Visual Effects In A Season Or A Movie category. ILP had the honour of contributing to 7 out of the 10 episodes for the FX series, which was led by overall VFX supervisor Michael Cliett, and won a record-breaking 14 Creative Arts Emmy awards and is poised to extend that streak at the Primetime Emmys later this week. With an emphasis on historical authenticity, ILP was responsible for large-scale full CG environments, vast crowd work, a devastating landslide and sweeping marine simulations. In addition to Shōgun, ILP was recognized with nominations for 2 of the remaining 4 visual effects nominees at this year’s awards: Netflix’s Avatar: The Last Airbender with Niklas Jacobson as VFX Supervisor and Amazon’s Fallout with Ahmed Gharraph as VFX Supervisor. Additionally, the studio was

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye